Eli Lilly LLY
NYSE LLY
$1,422.03 +10.08 (+0.71%)
As of: Nov 10, 2026 · 12:38 PM EST

Eli Lilly (LLY) Enterprise Value (2009 - 2026)

Updated

Eli Lilly (LLY) recorded Enterprise Value of $1.09 trillion in Q3 2026, up 52.6% from $711.47 billion a year earlier but down 3.1% from the prior quarter.

Analysis

Eli Lilly (LLY) Enterprise Value (2009 - 2026) Analysis & Trends

On a TTM basis, Eli Lilly's Enterprise Value came in at $1.06 trillion as of Sep 30, 2026, up 51.7% year-over-year; for FY2025, it came in at $1.01 trillion, up 38.1% from FY2024.

  • Annual Enterprise Value has increased for nine straight years, with a five-year compound annual growth rate of 44.8% (FY2020 to FY2025).
  • Across earlier years, Enterprise Value came in at $728.64 billion in FY2024 (+32.2%), $551.03 billion in FY2023 (+59.5%), $345.57 billion in FY2022 (+33.3%) and $259.32 billion in FY2021 (+63.8%).
  • Quarterly Enterprise Value has ranged from $259.32 billion in Q4 2021 to $1.12 trillion in Q2 2026 over the past five years.
  • On a year-over-year basis, Enterprise Value has increased for four consecutive quarters, with growth averaging 20.3% over the last eight quarters.
  • Peak year-over-year performance for Enterprise Value in the last five years was growth of 128.5% in Q1 2024, against a decline of 15.1% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.12 trillion (Q2 2026), $860.9 billion (Q1 2026) and $1.01 trillion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Vertex Pharmaceuticals 138.78 Bn 110.77 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1,085.67 Bn
Jun 30, 2026 1,120.14 Bn
Mar 31, 2026 860.90 Bn
Dec 31, 2025 1,006.54 Bn
Sep 30, 2025 711.47 Bn
Jun 30, 2025 734.32 Bn
Mar 31, 2025 779.61 Bn
Dec 31, 2024 728.64 Bn
Sep 30, 2024 837.60 Bn
Jun 30, 2024 857.21 Bn
Mar 31, 2024 736.88 Bn
Dec 31, 2023 551.03 Bn
Sep 30, 2023 507.49 Bn
Jun 30, 2023 442.46 Bn
Mar 31, 2023 322.43 Bn
Dec 31, 2022 345.57 Bn
Sep 30, 2022 304.59 Bn
Jun 30, 2022 305.45 Bn
Mar 31, 2022 269.66 Bn
Dec 31, 2021 259.32 Bn
API Access

Eli Lilly Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=LLY&period=max&api_key=YOUR_API_KEY